Skip to main content
American Journal of Cardiovascular Disease logoLink to American Journal of Cardiovascular Disease
. 2014 Jan 15;4(1):14–19.

Association between Framingham risk score and subclinical atherosclerosis among elderly with both type 2 diabetes mellitus and healthy subjects

Moatassem S Amer 1, Mohamed S Khater 1, Omar H Omar 2, Randa A Mabrouk 3, Shimaa A Mostafa 1
PMCID: PMC3925882  PMID: 24551481

Abstract

Framingham risk score (FRS) is a widely used tool to identify asymptomatic individuals who are at risk to cardiovascular disease. We aimed to investigate the association between subclinical atherosclerosis and FRS among elderly with both type 2 diabetes mellitus and healthy participants. Methods: As case-control study was done on 58 men and women, who had type 2 diabetes mellitus, and in 59 age and gender matched control participants. They were selected from a geriatric outpatient clinic at Ain Shams University Hospital, Cairo, Egypt. The carotid intima-media thickness (cIMT), clinical variables, plasma lipid profile, high-sensitivity C-reactive protein (hs-CRP) were measured for each participants. Results: Diabetic patients had higher FRS, body mass index (BMI), fasting glucose, total cholesterol level, and LDL levels than control subjects. Mean cIMT values were higher in diabetic than healthy subjects. After multivariate regression analysis, FRS was independently associated with carotid IMT in type 2 diabetes patients after adjustment for other risk factors. However triglycerides and BMI were independently associated with cIMT among the control group. Conclusion: FRS is likely to be more informative about the atherosclerotic state in diabetics but not in the healthy elderly.

Keywords: Framingham risk score, subclinical atherosclerosis, type 2 diabetes mellitus

Introduction

Patients with type 2 diabetes have a high incidence of atherosclerosis, which leads to increased morbidity and mortality from cardiovascular disease (CVD) [1-3]. Patients with T2D have a two to four fold increased incidence of CVD compared to persons without diabetes [4,5]. Furthermore diabetes has been related to subclinical atherosclerosis [6,7]. Framingham risk Score (FRS) is a simplified CVD prediction tool and has traditionally been used by clinicians worldwide to assess the risk of a cardiovascular event and to identify candidate patients for risk factor modifications [8-11]. The FRS takes into account six coronary risk factors, including age, gender, total cholesterol, high density lipoprotein (HDL)-cholesterol, systolic blood pressure, and smoking habits [12].

Atherosclerotic changes in the carotid arteries generally reflect systemic atherosclerosis and are predictive of atherosclerotic diseases such as cerebrovascular and coronary artery disease [13-15]. Determination of carotid intima-media thickness (cIMT) is a considered to be an accepted research method for detection and quantification of subclinical atherosclerosis [14,16-19].

From the available imaging techniques, measurement of cIMT with B-mode ultrasound is a non-invasive, sensitive, and highly reproducible technique for identifying and quantifying atherosclerotic changes. It is also a well-validated research tool, and is now increasingly used in clinical practice [20-22]. In fact, cIMT was shown to accurately represent anatomic structural abnormalities [20,21], that correlate with various classical and emerging cardiovascular risk (CV) factors and with prevalent CV disease [20-23]. It has also proved to be an independent predictor of myocardial infarction and stroke [24-26]. The American Heart Association and the Third Adult Treatment Panel of the National Cholesterol Education Program have endorsed the use of cIMT in CV risk assessment [27,28].

The aim of the study was to assess the association between subclinical atherosclerosis and FRS among elderly with both type 2 diabetes mellitus and healthy subjects.

Material and methods

The study was a case control study. One hundred and seventeen participants aged 60 and older were included in this study. They were selected from a geriatric outpatient clinic at Ain Shams University Hospital and divided into two groups. The control group consisted of 59 volunteers (28 males and 31 females) who had no evidence of medical disease after medical history, examination, and selected investigations; the diabetic group consisted of 58 participants (29 males and 29 females) who were known cases of diabetes mellitus type 2 or according to the basis of the World Health Organization (WHO) and American Diabetes Association (ADA) criteria: a fasting plasma glucose level ≥126 mg/dl and/or 2-h plasma glucose level after the 75 g oral glucose tolerance test ≥200 mg/dl [29,30]. Patients having other systemic disease(s), or taking medications known to affect inflammatory markers were excluded. All participants underwent clinical examinations, which included medical history and physical examination. The weight and height of each participant was measured while the participant was clothed only in light clothes, and body mass index (BMI) was calculated as body weight in kilograms divided by height in meter squared.

Laboratory examinations

A venous blood sample from the antecubital vein collected after an overnight fasting from every participant and centrifuged within 30 minutes; the serum samples were stored in the central laboratory of Ain Shams University Hospital at -70°C until the time of assay. High-sensitivity C-reactive protein (hs-CRP) was measured by enzyme-linked immunosorbent assay (ELISA) method using DiaMed EuroGen diagnostic Kit (Belgium). Serum triglycerides, total cholesterol, low-density lipoprotein (LDL), HDL, serum creatinine, and serum glucose were measured in the central laboratory of Ain Shams University Hospital.

The framingham risk score

FRS was calculated according to the adapted simplified model of Wilson et al, using the weighted risk factors: age, gender, total cholesterol, HDL cholesterol, smoking history, blood pressure, and diabetes mellitus [9].

Carotid artery IMT measurements

Carotid arterial duplex on both sides of the neck was performed using Hitachi EUB-565A B mode-Doppler with color imaging. It was done in the Interventional and Vascular Radiology Unit in Ain Shams University Hospital. The scanning protocol involved examination of the carotid arteries first in a transverse plane and then longitudinally. Measurement of IMT was made at a point on the far wall of the common carotid artery (CCA), 2 cm proximal to the bifurcation, from a longitudinal scan plane that showed the intima-media boundaries most clearly [31]. On the screen displaying the frozen magnified image of the far wall of the CCA, two cursors were positioned on the boundaries of the intima-media. The distance between these cursors was recorded to the nearest 0.1 mm (maximum axial resolution of the scanner) as the IMT. The procedure was repeated for each side of the neck. Average values derived from data of both sides were used for the analysis.

Informed consent was obtained from the participants. The study protocol conforms to the ethical guidelines of the 1975 Declaration of Helsinki and has been approved by the Institutional Review Board.

Statistical analysis

Statistical analysis performed by using the 16th version of Statistical Package of Social Science (SPSS). Description of all data in the form of mean and standard deviation (SD) for all quantitative variables. Frequency and percentage for all qualitative variables. Comparison of qualitative variables was done using Chi-square test. Comparison between quantitative variables was done using t-test to compare two groups. Correlation coefficient was also done to find linear relation between different variables using r-test or Spearman correlation co-efficient. Multivariate linear regression analysis was used to identify variables independently associated with cIMT among both groups. Significant level measured according to P value (Probability), P>0.05 insignificant, P<0.05 significant and P<0.01 highly significant.

Results

The clinical characteristics of the diabetic and control groups are presented in Table 1, there is no difference between the studied two groups regarding age, smoking status, and HDL level. However diabetic patients had higher FRS, BMI, fasting glucose, total cholesterol level, and LDL levels than the control group. Carotid artery IMT was significantly higher in diabetic patients compared with the control group (p<0.001).

Table 1.

Clinical characteristics of study participants

Type 2 diabetes (n=58) Control group (n=59) p-value
Age, years 65.8 ± 5.6 64.1 ± 4.6 0.276
Gender (male/female) 29/29 28/31 0.854
Smokers (%) 28 (46.7%) 16 (26.7%) 0.068
BMI, Kg/m2 31.3 ± 7.1 27.5 ± 4.8 0.001
Diabetes duration, years 12.8 ± 5.8 -- --
Fasting glucose, mg/dL 153.7 ± 41.0 85.2 ± 7.8 <0.001
2-h pp blood glucose, mg/dL 247.6 ± 77.5 118.9 ± 11.9 <0.001
Triglycerides level, mg/dL 134.8 ± 45.2 113.7 ± 21.0 0.066
Total cholesterol level, mg/dL 222.3 ± 33.9 171.2 ± 50.2 <0.001
LDL level, mg/dL 152.1 ± 26.1 131.9 ± 26.4 <0.001
HDL level, mg/dL 39.4 ± 7.0 41.5 ± 7.7 0.056
Hs-CRP level, mg/dL 7.3 ± 0.2 4.6 ± 2.3 <0.001
Carotid artery IMT, mm 1.14 ± 0.2 0.69 ± 0.2 <0.001
FRS 28.9 ± 11.6 9.8 ± 4.9 <0.001

Abbreviations: BMI = body mass index; 2-h pp = 2 hours post prandial; LDL = low-density lipoprotein; HDL = high-density lipoprotein; Hs-CRP = high-sensitivity C-reactive protein; IMT = intima-media thickness; FRS = Framingham risk score.

Among the diabetic and control participants there was no significant association between cIMT with gender (p=0.867; 0.592) and smoking status (P=0.898; 0.0506) respectively. Table 2 shows the Pearson correlation analysis between cIMT with age, BMI, diabetes duration, fasting glucose, 2-hours postprandial blood glucose and lipid profile among both the diabetic patients and the control group. Among the diabetic patients cIMT had significant positive correlation with the duration of diabetes, serum triglycerides, hs-CRP level and FRS. Among the control group cIMT was significantly positive correlated with BMI, serum triglycerides and hs-CRP level. However there was there was no significant association between cIMT and other variables.

Table 2.

Pearson correlations between carotid IMT and the study variables among both diabetic and control groups

Diabetic group Control group

r p-value r p-value
Age -0.103 0.442 -0.062 0.640
BMI 0.206 0.121 0.320 0.013
Diabetes duration 0.306 0.019 - -
HDL level -0.022 0.869 -0.002 0.990
LDL level 0.233 0.079 0.071 0.594
Total cholesterol level 0.044 0.744 0.038 0.773
Triglycerides 0.270 0.041 0.105 0.005
Fasting glucose 0.007 0.955 0.120 0.365
Hs-CRP 0.313 0.017 0.322 0.013
FRS 0.401 0.002 0.073 0.583

Abbreviations: IMT = intima-media thickness; BMI = body mass index; HDL = high-density lipoprotein; LDL = low-density lipopro- tein; Hs-CRP = high-sensitivity C-reactive protein; FRS = Framingham risk score.

Multiple linear regression analysis was performed using the cIMT as dependent variable and the duration of diabetes, triglycerides, hs-CRP level and FRS as independent variables among the diabetic group Table 3. Another Multiple linear regression analysis was performed using the cIMT as dependent variable and BMI, triglycerides and hs-CRP levels as independent variables among the control group Table 4.

Table 3.

Multiple linear regression with the dependent variable Carotid IMT among diabetic group

Parameter Standardized coefficients, β p-value
FRS 0.005 0.012
Hs-CRP 0.009 0.119
Triglycerides 0.006 0.096
Diabetes duration 0.001 0.243

Abbreviations: IMT = intima-media thickness; FRS = Framingham risk score; Hs-CRP = high-sensitivity C-reactive protein.

Table 4.

Multiple linear regression with the dependent variable Carotid IMT among control group

Parameter Standardized coefficients, β p-value
BMI 0.010 0.025
Hs-CRP 0.017 0.078
Triglycerides 0.003 0.004

Abbreviations: IMT = intima-media thickness; BMI = body mass index; Hs-CRP = high-sensitivity C-reactive protein.

Of the independent variables the FRS was more associated with carotid artery IMT, after adjustment of other factors, among the diabetic group. However BMI and triglyceride levels were independently associated with cIMT among the control group.

Discussion

Current guidelines for primary prevention of CVD recommend initial assessment and risk stratification based on traditional risk factor scoring used to identify asymptomatic individuals with atherosclerosis who may benefit from more aggressive primary preventive therapy [32].

The FRS is a useful tool for identifying those subjects, FRS has been shown to be significantly associated with cIMT in asymptomatic adults [33,34].

In this study we assessed the association/relationship between subclinical atherosclerosis and FRS among both elderly with diabetes and healthy participants. Our results showed that, after adjustment of other variables, FRS was only associated with SCA among the diabetic participants but this association wasn’t present in healthy participants.

As previously shown in several studies we found that cIMT was associated with BMI and triglyceride levels among healthy participants and with FRS among diabetic participants.

Several studies have shown that a considerable number of subjects classified as low risk by FRS have subclinical atherosclerosis. In a cross-sectional study assessing the prevalence and predictors of subclinical atherosclerosis among asymptomatic individuals in a multiethnic population found that 23% of individuals classified to be at low risk according to the FRS have SCA [35]. In another study thirty-eight percent of asymptomatic young to middle-aged individuals with FRS ≤5% have abnormal carotid ultrasound findings associated with increased risk for CV events [36]. In a study by Karim et al., an even higher prevalence of 69% was reported [37].

Therefore, conventional risk stratification using the Framingham model misses an important proportion of individuals at risk of future CV events [35]. However, the results of the current study showed that in the high risk group (diabetic patients) FRS reflects SCA accurately.

This underestimation of subclinical atherosclerosis among the healthy participants could be attributed to the limitations of FRS, which does not account for some important coronary heart disease (CHD) risk factors such as family history of CHD, previous history of CHD, race, obesity, and systemic diseases such as systemic lupus erythematosus or rheumatoid arthritis [34,38-42]. In addition, diabetes and smoking are identified only as present or absent, although current evidence supports a continuous relationship between glycemia and tobacco exposure to CHD risk [43,44].

The current study concluded that FRS, while an accurate predictor of atherosclerotic risk in diabetics, failed to reflect atherosclerotic state in healthy participants when compared to cIMT.

Disclosure of conflict of interest

None.

References

  • 1.Kannel WB, MacGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care. 1979;2:120–126. doi: 10.2337/diacare.2.2.120. [DOI] [PubMed] [Google Scholar]
  • 2.DeFronzo RA. Pathogenesis of type 2 (non-insulin-dependent) diabetes mellitus: a balanced overview. Diabetologia. 1992;35:389–397. doi: 10.1007/BF00401208. [DOI] [PubMed] [Google Scholar]
  • 3.Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and nondiabetic subjects and without prior myocardial infarction. N Engl J Med. 1998;339:229–234. doi: 10.1056/NEJM199807233390404. [DOI] [PubMed] [Google Scholar]
  • 4.Almdal T, Scharling H, Jensen JS, Vestergaard H. The independent effect of type 2 diabetes mellitus on ischemic heart disease, stroke, and death: a population-based study of 13,000 men and women with 20 years of follow-up. Arch Intern Med. 2004;164:1422–1426. doi: 10.1001/archinte.164.13.1422. [DOI] [PubMed] [Google Scholar]
  • 5.Booth GL, Kapral MK, Fung K, Tu JV. Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study. Lancet. 2006;368:29–36. doi: 10.1016/S0140-6736(06)68967-8. [DOI] [PubMed] [Google Scholar]
  • 6.Wagenknecht LE, D’Agostino RB Jr, Haffner SM, Savage PJ, Rewers M. Impaired glucose tolerance, type 2 diabetes, and carotid wall thickness: the Insulin Resistance Atherosclerosis study. Diabetes Care. 1998;21:1812–1818. doi: 10.2337/diacare.21.11.1812. [DOI] [PubMed] [Google Scholar]
  • 7.Kawamori R, Yamasaki Y, Matsushima H, Nishizawa H, Nao K, Hougaku H, Maeda H, Handa N, Matsumoto M, Kamada T. Prevalence of carotid atherosclerosis in diabetic patients: ultrasound high-resolution B-mode imaging on carotid arteries. Diabetes Care. 1992;15:1290–1294. doi: 10.2337/diacare.15.10.1290. [DOI] [PubMed] [Google Scholar]
  • 8.Leaverton PE, Sorlie PD, Kleinman JC, Dannenberg AL, Ingster-Moore L, Kannel WB, Cornoni-Huntley JC. Representativeness of the Framingham risk model for coronary heart disease mortality: a comparison with a national cohort study. J Chronic Dis. 1987;40:775–784. doi: 10.1016/0021-9681(87)90129-9. [DOI] [PubMed] [Google Scholar]
  • 9.Wilson PW, D’Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation. 1998;97:1837–1847. doi: 10.1161/01.cir.97.18.1837. [DOI] [PubMed] [Google Scholar]
  • 10.Liew SM, Doust J, Glasziou P. Cardiovascular risk scores do not account for the effect of treatment: a review. Heart. 2011;97:689–697. doi: 10.1136/hrt.2010.220442. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Albert MA, Glynn RJ, Ridker PM. Plasma concentration of C-reactive protein and the calculated Framingham Coronary Heart Disease Risk Score. Circulation. 2003;108:161–165. doi: 10.1161/01.CIR.0000080289.72166.CF. [DOI] [PubMed] [Google Scholar]
  • 12.Ford ES, Giles WH, Mokdad AH. The distribution of 10-year risk for coronary heart disease among US adults: findings from the National Health and Nutrition Examination Survey III. J Am Coll Cardiol. 2004;43:1791–1796. doi: 10.1016/j.jacc.2003.11.061. [DOI] [PubMed] [Google Scholar]
  • 13.Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–1249. doi: 10.1161/01.atv.11.5.1245. [DOI] [PubMed] [Google Scholar]
  • 14.O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. Cardiovascular health study collaborative research group. N Engl J Med. 1999;340:14–22. doi: 10.1056/NEJM199901073400103. [DOI] [PubMed] [Google Scholar]
  • 15.Mannami T, Konishi M, Baba S, Nishi N, Terao A. Prevalence of asymptomatic carotid atherosclerotic lesions detected by high-resolution ultrasonography and its relation to cardiovascular risk factors in the general population of a Japanese city: the Suita study. Stroke. 1997;28:518–525. doi: 10.1161/01.str.28.3.518. [DOI] [PubMed] [Google Scholar]
  • 16.Bots ML, Hoes AW, Koudstaal PJ, Hofman A, Grobbee DE. Common carotid intima-media thickness and risk of stroke and myocardial infarction: the Rotterdam Study. Circulation. 1997;96:1432–1437. doi: 10.1161/01.cir.96.5.1432. [DOI] [PubMed] [Google Scholar]
  • 17.Chambless LE, Folsom AR, Clegg LX, Sharrett AR, Shahar E, Nieto FJ, Rosamond WD, Evans G. Carotid wall thickness is predictive of incident clinical stroke: the Atherosclerosis Risk in Communities (ARIC) study. Am J Epidemiol. 2000;151:478–487. doi: 10.1093/oxfordjournals.aje.a010233. [DOI] [PubMed] [Google Scholar]
  • 18.Touboul PJ, Labreuche J, Vicaut E, Amarenco P GENIC Investigators. Carotid Intima-Media Thickness, Plaques, and Framingham Risk Score as Independent Determinants of Stroke Risk. Stroke. 2005;36:1741–1745. doi: 10.1161/01.STR.0000174490.23495.57. [DOI] [PubMed] [Google Scholar]
  • 19.Yamasaki Y, Kodama M, Nishizawa H, Sakamoto K, Matsuhisa M, Kajimoto Y, Kosugi K, Shimizu Y, Kawamori R, Hori M. Carotid intima-media thickness in Japanese type 2 diabetic subjects: predictors of progression and relationship with incident coronary heart disease. Diabetes Care. 2000;23:1310–1315. doi: 10.2337/diacare.23.9.1310. [DOI] [PubMed] [Google Scholar]
  • 20.Gepner AD, Keevil JG, Wyman RA, Korcarz CE, Aeschlimann SE, Busse KL, Stein JH. Use of carotid intima-media thickness and vascular age to modify cardiovascular risk prediction. J Am Soc Echocardiogr. 2006;19:1170–4. doi: 10.1016/j.echo.2006.04.009. [DOI] [PubMed] [Google Scholar]
  • 21.Simon A, Gariepy J, Chironi G, Megnien JL, Levenson J. Intima-media thickness: a newtool for diagnosis and treatment of cardiovascular risk. J Hypertens. 2002;20:159–69. doi: 10.1097/00004872-200202000-00001. [DOI] [PubMed] [Google Scholar]
  • 22.Roman MJ, Naqvi TZ, Gardin JM, Gerhard-Herman M, Jaff M, Mohler E American Society of Echocardiography; Society for Vascular Medicine and Biology. Clinical application of noninvasive vascular ultrasound in cardiovascular risk stratification: a report from the American Society of Echocardiography and the Society of Vascular Medicine and Biology. J Am Soc Echocardiogr. 2006;19:943–54. doi: 10.1016/j.echo.2006.04.020. [DOI] [PubMed] [Google Scholar]
  • 23.Heiss G, Sharrett AR, Barnes R, Chambless LE, Szklo M, Alzola C. Carotid atherosclerosis measured by B-mode ultrasound in populations: associations with cardiovascular risk factors in the ARIC study. Am J Epidemiol. 1991;134:250–6. doi: 10.1093/oxfordjournals.aje.a116078. [DOI] [PubMed] [Google Scholar]
  • 24.Salonen JT, Salonen R. Ultrasonographically assessed carotid morphology and the risk of coronary heart disease. Arterioscler Thromb. 1991;11:1245–9. doi: 10.1161/01.atv.11.5.1245. [DOI] [PubMed] [Google Scholar]
  • 25.Chambless LE, Heiss G, Folsom AR, Rosamond W, Szklo M, Sharrett AR, Clegg LX. Association of coronary heart disease incidence with carotid arterial wall thickness and major risk factors: the ARIC study. Am J Epidemiol. 1997;146:483–94. doi: 10.1093/oxfordjournals.aje.a009302. [DOI] [PubMed] [Google Scholar]
  • 26.O’Leary DH, Polak JF, Kronmal RA, Manolio TA, Burke GL, Wolfson SK Jr. Carotid-artery intima and media thickness as a risk factor for myocardial infarction and stroke in older adults. N Engl J Med. 1999;340:14–22. doi: 10.1056/NEJM199901073400103. [DOI] [PubMed] [Google Scholar]
  • 27.Greenland P, Smith SC, Grundy SM. Improving coronary heart disease risk assessment in asymptomatic people: role of traditional risk factors and noninvasive cardiovascular tests. Circulation. 2001;104:1863–7. doi: 10.1161/hc4201.097189. [DOI] [PubMed] [Google Scholar]
  • 28.National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high blood pressure in adults (ATP III) Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation and treatment of high cholesterol in adults (ATP III) final report. Circulation. 2002;106:3121–43. [PubMed] [Google Scholar]
  • 29.World Health Organization. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Geneva: World Health Organization; 2006. [Google Scholar]
  • 30.American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care. 2008;31:S55–S60. doi: 10.2337/dc08-S055. [DOI] [PubMed] [Google Scholar]
  • 31.Ginsberg MD, Cebul RD. Non-invasive diagnosis of carotid artery disease. In: Harrison MJG, Dyken ML, editors. Cerebral Vascular Disease. London, UK: Butterworth; 1983. p. 226. [Google Scholar]
  • 32.World Health Statistics. http://www.who.int/healthinfo/en/index.html [accessed, September 3, 2013]
  • 33.Kieltyka L, Urbina EM, Tang R, Bond MG, Srinivasan SR, Berenson GS. Framingham risk score is related to carotid artery intima-media thickness in both white and black young adults: the Bogalusa Heart Study. Atherosclerosis. 2003;170:125–130. doi: 10.1016/s0021-9150(03)00244-2. [DOI] [PubMed] [Google Scholar]
  • 34.Mahoney LT, Burns TL, Stanford W, Thompson BH, Witt JD, Rost CA, Lauer RM. Usefulness of the Framingham risk score and body mass index to predict early coronary artery calcium in young adults (Muscatine Study) Am J Cardiol. 2001;88:509–515. doi: 10.1016/s0002-9149(01)01728-3. [DOI] [PubMed] [Google Scholar]
  • 35.Grewal J, Anand S, Islam S, Lonn E. Prevalence and predictors of subclinical atherosclerosis among asymptomatic “low risk” Individuals in a multiethnic population. Atherosclerosis. 2008;197:435–442. doi: 10.1016/j.atherosclerosis.2007.06.020. [DOI] [PubMed] [Google Scholar]
  • 36.Eleid MF, Lester SJ, Wiedenbeck TL, Patel SD, Appleton CP, Nelson MR, Humphries J, Hurst RT. Carotid ultrasound identifies high risk subclinical atherosclerosis in adults with low framingham risk scores. J Am Soc Echocardiogr. 2010;23:802–808. doi: 10.1016/j.echo.2010.06.003. [DOI] [PubMed] [Google Scholar]
  • 37.Karim R, Hodis HN, Detrano R, Liu CR, Liu CH, Mack WJ. Relation of Framingham risk score to subclinical atherosclerosis evaluated across three arterial sites. Am J Cardiol. 2008;102:825–830. doi: 10.1016/j.amjcard.2008.05.039. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Akosah KO, Schaper A, Cogbill C, Schoenfeld P. Preventing myocardial infarction in the young adult in the first place: how do the National Cholesterol Education Panel III guidelines perform? J Am Coll Cardiol. 2003;41:1475–1479. doi: 10.1016/s0735-1097(03)00187-6. [DOI] [PubMed] [Google Scholar]
  • 39.Hecht HS. Impact of plaque imaging by electron beam tomography on the treatment of dyslipidemias. Am J Cardiol. 2001;88:406–408. doi: 10.1016/s0002-9149(01)01688-5. [DOI] [PubMed] [Google Scholar]
  • 40.Chung CP, Oeser A, Avalos I, Gebretsadik T, Shintani A, Raggi P, Sokka T, Pincus T, Stein CM. Utility of the Framingham risk score to predict the presence of coronary atherosclerosis in patients with rheumatoid arthritis. Arthritis Res Ther. 2006;8:R186. doi: 10.1186/ar2098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41.Chung CP, Oeser A, Avalos I, Raggi P, Stein CM. Cardiovascular risk scores and the presence of subclinical coronary artery atherosclerosis in women with systemic lupus erythematosus. Lupus. 2006;15:562–569. doi: 10.1177/0961203306071870. [DOI] [PubMed] [Google Scholar]
  • 42.Michos ED, Nasir K, Rumberger JA, Vasamreddy C, Braunstein JB, Budoff MJ, Blumenthal RS. Relation of family history of premature coronary heart disease and metabolic risk factors to risk of coronary arterial calcium in asymptomatic subjects. Am J Cardiol. 2005;95:655–657. doi: 10.1016/j.amjcard.2004.10.045. [DOI] [PubMed] [Google Scholar]
  • 43.Teo KK, Ounpuu S, Hawken S, Pandey MR, Valentin V, Hunt D, Diaz R, Rashed W, Freeman R, Jiang L, Zhang X, Yusuf S INTERHEART Study Investigators. Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study. Lancet. 2006;368:647–58. doi: 10.1016/S0140-6736(06)69249-0. [DOI] [PubMed] [Google Scholar]
  • 44.Coutinho M, Gerstein HC, Wang Y, Yusuf S. The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12.4 years. Diabetes Care. 1999;22:233–40. doi: 10.2337/diacare.22.2.233. [DOI] [PubMed] [Google Scholar]

Articles from American Journal of Cardiovascular Disease are provided here courtesy of e-Century Publishing Corporation

RESOURCES